Last updated on February 2019

Maintenance Treatment of Renal Anemia in Dialysis Subjects

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of molidustat in comparison to darbepoetin alfa in dialysis subjects with renal anemia who are treated with Erythropoiesis-Stimulating Agents (ESAs).

Clinical Study Identifier: NCT03543657

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Oohashi internal medicine circulatory Clinic
Fukuoka, Japan

Bayer Clinical Trials Contact

Ikeda Vascular Access Nephrology Dialysis
Fukuoka, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.